The role of anti-endothelial cell antibody-mediated microvascular injury in the evolution of pulmonary fibrosis in the setting of collagen vascular disease.
American Journal of Clinical Pathology.
Times cited: 35
Promising pharmacologic innovations in treating pulmonary fibrosis.
Current Opinion in Pharmacology.
Times cited: 23
Idiopathic Pulmonary Fibrosis Related to Endothelial Injury and Antiendothelial Cell Antibodies.
Times cited: 48